Drugs Aging September 2023 PMID 37603255

Theoretical Underpinnings of a Model to Reduce Polypharmacy and Its Negative Health Effects: Introducing the Team Approach to Polypharmacy Evaluation and Reduction (TAPER).

Dee Mangin, Larkin Lamarche, Jeffrey A Templeton, Jennifer Salerno, Henry Siu, Johanna Trimble, Abbas Ali, Jobin Varughese, Amy Page, Christopher Etherton-Beer

Download social card

Mentions

10
Peak: 1 in Jun 2022
across 4 sources since Jun 2022

Extended reach

6,441
potential audience

Total likes

1

Video views

18

Mentions per month

Jun 2022 – Dec 2023

Where it's discussed

  • X / Twitter3 posts
  • Facebook3 posts
  • Reddit3 posts
  • YouTube1 videos

AI synopsis

What people are saying

The overall tone shows high enthusiasm for the TAPER model, with comments emphasizing its theoretical soundness and applicability, such as mentions of tailored approaches and healthcare system improvements. Words like 'outline,' 'develop,' and 'aims' reflect a focus on the model's significance and potential impact, demonstrating thoughtful engagement and recognition of its transformative potential.

AgreementModerate agreement

Most discussions acknowledge the importance of the TAPER model and support its theoretical foundation and purpose in reducing polypharmacy.

InterestHigh interest

The topic resonates strongly with those interested in healthcare, medication safety, and innovative models, leading to high levels of engagement and curiosity.

EngagementModerate engagement

Participants reference specific aspects like patient-centered goals and multidisciplinary approaches, indicating meaningful engagement with the content.

ImpactModerate impact

The discussions highlight potential improvements in medication management, suggesting the publication could influence clinical practices and healthcare policies.

Abstract in brief

  • The article discusses how polypharmacy, especially among older adults, poses health risks due to drug interactions, side effects, and the challenges of managing multiple medications, highlighting the need for more effective interventions.
  • It introduces the TAPER (Team Approach to Polypharmacy Evaluation and Reduction) model, which is designed to overcome barriers at patient, provider, and system levels by using the chronic care model framework to guide behavioral change and improve medication management.
  • The development of TAPER maps onto established healthcare models like the chronic care model, minimally disruptive medicine, and the cumulative complexity model, aligning with primary care principles to create a comprehensive approach to reducing unnecessary polypharmacy and its negative effects.

Top posts

Most liked on X and Bluesky
McMaster Family Med
@McMasterFamMed · X

.@DeeMangin and research team outline the theoretical development of TAPER in this recently published article. TAPER is an intervention that aims to reduce polypharmacy using a team approach tailored to the patients’ goals & priorities. Learn more: https://t.co/M8GtzkzI3g

Sep 1, 2023 · 1 like · 1 share · 3,622 followers View post →
US Deprescribing Research Network (USDeN)
@DeprescribeUS · X

RT @DeprescribeAU: Theoretical Underpinnings of a Model to Reduce Polypharmacy and Its Negative Health Effects: Introducing the Team Approa…

Nov 30, 2023 · 3 shares · 2,462 followers View post →

All mentions

Reddit Journal of Science
@rsciencejournal · X

Theoretical Underpinnings of a Model to Reduce Polypharmacy and Its Negative Health Effects: Introducing the Team Approach to Polypharmacy Evaluation and Reduction (TAPER) https://t.co/oOf3ur8aJi #science #health #polypharmacy #underpinnings #model #reduce

Dec 2, 2023 · 331 followers View post →
US Deprescribing Research Network (USDeN)
@DeprescribeUS · X

RT @DeprescribeAU: Theoretical Underpinnings of a Model to Reduce Polypharmacy and Its Negative Health Effects: Introducing the Team Approa…

Nov 30, 2023 · 3 shares · 2,462 followers View post →
McMaster Family Med
@McMasterFamMed · X

.@DeeMangin and research team outline the theoretical development of TAPER in this recently published article. TAPER is an intervention that aims to reduce polypharmacy using a team approach tailored to the patients’ goals & priorities. Learn more: https://t.co/M8GtzkzI3g

Sep 1, 2023 · 1 like · 1 share · 3,622 followers View post →